Stroke Trial, Recruiting NCT06210633 Sponsor: Zhongming Qiu Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06210633
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have had an acute ischemic stroke (a stroke caused by a blocked blood vessel) within 24 hours of when they were last known to be well
  • People (or their representative) who are able to sign a written consent form before joining the trial
  • People whose brain scans (CT scan, MRI, or similar imaging) show a blockage in a specific artery in the brain — either the internal carotid artery or parts of the middle cerebral artery
  • People whose brain scans show a large area of brain affected by the stroke, based on specific scoring or measurement criteria used by the medical team

Who may not be able to join:

  • People whose brain scans show signs of active bleeding inside the skull
  • People whose brain scans show signs of significant brain swelling or shifting of brain structures
  • People who are pregnant, or people of childbearing potential whose pregnancy test comes back positive
  • People with a history of bleeding disorders, or serious heart, liver, or kidney disease, or a severe blood infection (sepsis)
  • People who have a terminal illness with a life expectancy of less than 6 months
  • People who are already taking part in another clinical treatment trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Guangxiong Yuan, Xiangtan Central Hospital

Phone: +8613236599269

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Zhongming Qiu
Registry
ClinicalTrials.gov
Start date
20 January 2024
Est. completion
31 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Modified Rankin Scale score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov